ClassID:

20523

A61K31/7048 - page 7 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin

Recent Application in this class:
#1801
20190040094
2019-02-07

Process for the preparation of D-glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl] oxy]phenyl] methyl] phenyl]-, (1S) and its crystalline forms thereof

#1802
20190038759
2019-02-07

Cleavable conjugates of antibiotics and an antibacterial cell-penetrating peptide

#1803
20190038693
2019-02-07

Vaporized medicants and methods of use

#1804
20190038690
2019-02-07

Method for preparing herbal composition having increased fat-solublepolyphenol content, herbal composition prepared thereby and use thereof

#1805
20190038655
2019-02-07

Chemicals and methods to prevent and treat TGF-beta mediated activation of fibroblasts to reduce and treat cancer and fibrosis

#1806
20190038654
2019-02-07

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#1807
20190038653
2019-02-07

COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY DISEASES

#1808
20190033292
2019-01-31

Methods of screening and treatment with USP4 inhibitors

#1809
20190033290
2019-01-31

DIAGNOSIS AND TREATMENT OF INVASIVE ASPERGILLOSIS

#1810
20190030055
2019-01-31

TOPICAL ANTIFUNGAL PASTES AND METHODS OF USE THEREOF

#1811
20190029972
2019-01-31

Sulfur(VI) fluoride compounds and methods for the preparation thereof

#1812
20190029958
2019-01-31

COSMETIC AND PHARMACEUTICAL FOAM

#1813
20190022177
2019-01-24

Composition comprising an algal proteoglycan extract and use thereof

#1814
20190022081
2019-01-24

Methods for solid tumor treatment

#1815
20190022056
2019-01-24

Polyphenol-reactive oxygen species compositions and methods

#1816
20190022018
2019-01-24

Biomembrane, closed structure with biomembrane characteristics or cellular compartment derived from natural sources and/or self-assembly techniques, preparation method and applications thereof

#1817
20190015448
2019-01-17

Treatment and Prevention of Bone and Joint Disorders

#1818
20190015438
2019-01-17

Methods for treating infection including sepsis via P2X receptor modulation

#1819
20190015437
2019-01-17

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#1820
20190015414
2019-01-17

Formulations of 5-fluorocytosine and uses thereof

#1821
20190015400
2019-01-17

Antifungal Compositions

#1822
20190015384
2019-01-17

Treatment and prevention of joint disorders

#1823
20190008862
2019-01-10

PDE III inhibitors for treatment of asymptomatic heart failure

#1824
20190008860
2019-01-10

Agent for preventing and/or treating Alzheimer's disease

#1825
20190008803
2019-01-10

COMBINATIONS OF OPIOID RECEPTOR LIGANDS AND CYTOCHROME P450 INHIBITORS

#1826
20190008747
2019-01-10

EXTERNAL DERMAL COMPOSITION FOR ANTI-AGEING AND METHOD FOR PRODUCING THE SAME

#1827
20190008723
2019-01-10

Container assembly

#1828
20190001160
2019-01-03

Use of carrimycin in infection resistance

#1829
20190000931
2019-01-03

DIETARY SUPPLEMENTS AND FORMULATIONS

#1830
20190000930
2019-01-03

DIETARY SUPPLEMENTS AND FORMULATIONS

#1831
20190000869
2019-01-03

Composition, containing Loganin or a derivative thereof as an active ingredient for preventing, remedying, or treating female climacteric syndrome

#1832
20190000868
2019-01-03

COMPOSITIONS COMPRISING 4'-O-GLUCURONIDE EPICATECHIN AND METHODS OF MAKING AND USING SUCH COMPOSITIONS

#1833
20190000867
2019-01-03

COMPOUNDS, COMPOSITIONS AND METHODS FOR PROTECTING BRAIN HEALTH IN NEURODEGENERATIVE DISORDERS

#1834
20190000797
2019-01-03

Tumor therapeutic agent

#1835
20190000786
2019-01-03

Methods of diagnosing and treating infected implants

#1836
20180369316
2018-12-27

Proteasome modulation for treatment of corneal disorders

#1837
20180369281
2018-12-27

Method of ameliorating side effects of sickle cell disease treatments

#1838
20180369264
2018-12-27

COMBINATION OF A CARDIAC STEROID AND AN AKT INHIBITOR FOR THE TREATMENT OF CARDIOVASCULAR DISEASES AND DISORDERS

#1839
20180369263
2018-12-27

Therapeutic method and therapeutic agent for atopic dermatitis in animals

#1840
20180369262
2018-12-27

METHODS FOR TREATING RESISTANT DISEASES USING TRIAZOLE CONTAINING MACROLIDES

#1841
20180363033
2018-12-20

Biomarkers for predicting infection treatment outcome

#1842
20180362514
2018-12-20

Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof

#1843
20180360841
2018-12-20

HSPC-sparing treatments for Rb-positive abnormal cellular proliferation

#1844
20180360840
2018-12-20

Transient protection of normal cells during chemotherapy

#1845
20180360826
2018-12-20

Pharmaceutical compositions comprising clofazimine analog compound B746 or clofazimine analog compound B826

#1846
20180360816
2018-12-20

Animal treatments

#1847
20180360760
2018-12-20

Methods for administering weight loss medications

#1848
20180353528
2018-12-13

Methods of preventing or treating filovirus and flavivirus diseases

#1849
20180353527
2018-12-13

Compositions and methods using a polyphenol for musculoskeletal health

#1850
20180353513
2018-12-13

Uses of DPP IV inhibitors

#1851
20180344788
2018-12-06

Composition containing Oroxylin A and method of extraction thereof

#1852
20180344782
2018-12-06

Probiotic recolonisation therapy

#1853
20180344757
2018-12-06

Use of ivermectin and brimonidine in the treatment and/or prevention of moderate to severe rosacea

#1854
20180344708
2018-12-06

METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS

#1855
20180344689
2018-12-06

Complex of a glucopyranosyl derivative and preparation method and use thereof

#1856
20180344683
2018-12-06

DRUG FOR PREVENTING AND TREATING ALOPECIA

#1857
20180344657
2018-12-06

Nanoparticles for treatment of posterior segment ocular diseases and conditions

#1858
20180344647
2018-12-06

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#1859
20180344633
2018-12-06

USE OF ENZYME-MODIFIED ISOQUERCITRIN

#1860
20180339010
2018-11-29

Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease

#1861
20180338947
2018-11-29

COMPOSITIONS FOR ANTI-INFLAMMATORY, ANTIOXIDANT EFFECTS AND IMPROVED RESPIRATORY FUNCTION BY SPECIFIC HISTONE DEACETYLASE INHIBITION

#1862
20180338931
2018-11-29

Use of cannabinoids in the treatment of epilepsy

#1863
20180338924
2018-11-29

SOLID PHARMACEUTICAL DOSAGE FORM FOR RELEASE OF AT LEAST ONE ACTIVE PHARMACEUTICAL INGREDIENT IN THE ORAL CAVITY

#1864
20180338917
2018-11-29

Compositions for delivery of drug combinations

#1865
20180325940
2018-11-15

Composition for ameliorating loss of hair and graying of hair, and use thereof

#1866
20180325931
2018-11-15

USE OF PAEONIFLORIN-6'-O-BENZENESULFONATE IN TREATMENT OF SJÖGREN'S SYNDROME

#1867
20180325919
2018-11-15

Antifungal agents used in combination

#1868
20180325897
2018-11-15

Co-crystals and pharmaceutical compositions comprising the same

#1869
20180325890
2018-11-15

Methods and pharmaceutical compostions for treating rhabdomyolysis

#1870
20180325859
2018-11-15

Compositions comprising a compound from the family of avermectins and an agonist compound for at least one of the retinoic acid receptors for treating acne

#1871
20180318345
2018-11-08

Methods of inhibiting the virulence of a pathogen with an oxidized tannin to treat a gastrointestinal spasm

#1872
20180318329
2018-11-08

Compositions and methods of treating acne and photoaging

#1873
20180318328
2018-11-08

Therapy for inhibition of single-stranded RNA virus replication

#1874
20180318251
2018-11-08

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#1875
20180316309
2018-11-01

SNS-595 AND METHODS OF USING THE SAME

#1876
20180311267
2018-11-01

Methods for treating pulmonary non-tuberculous mycobacterial infections

#1877
20180311249
2018-11-01

Combination therapy for treating malignancies

#1878
20180303918
2018-10-25

Oral dissolving films

#1879
20180303891
2018-10-25

Specific nutritional or therapeutic agent including a mixture of grape and blueberry

#1880
20180303863
2018-10-25

Pharmaceutical Composition for Treating STK11-Mutation Cancer Using Cardiac Glycosides

#1881
20180303808
2018-10-25

Combination therapy for treating malignancies

#1882
20180303794
2018-10-25

Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

#1883
20180303769
2018-10-25

Inhibition of multiple pathogenic agents using bithionol

#1884
20180296638
2018-10-18

Compositions for treating heart disease by inhibiting the action of mAKAP-β

#1885
20180296482
2018-10-18

Process for preparing a composition comprising a high concentration of one or more avermectins

#1886
20180289767
2018-10-11

Compositions and methods for invasive and non-invasive procedural skincare

#1887
20180289732
2018-10-11

Process for preparing a stable emulsion comprising one or more avermectins

#1888
20180282731
2018-10-04

Oligonucleotides for modulating gene expression and uses thereof

#1889
20180280473
2018-10-04

Formulation for targeting cancer in humans and canines using chlorotoxin

#1890
20180280449
2018-10-04

Formulation for targeting cancer in humans and canines using venom

#1891
20180280380
2018-10-04

Combination of opioids and anticancer drugs for cancer treatment

#1892
20180280300
2018-10-04

LIPOSOME INCLUDING TAXANE COMPOUND

#1893
20180279613
2018-10-04

Combinations of acaricides and insect growth regulators for control of fleas without emesis in animals

#1894
20180271888
2018-09-27

COMPOSITIONS AND METHODS FOR PARKINSON'S DISEASE THERAPY

#1895
20180265536
2018-09-20

Use of avermectin derivative for increasing bioavailability and efficacy of macrocyclic lactones

#1896
20180264028
2018-09-20

Combination therapy for EV71 infection

#1897
20180264021
2018-09-20

Treatment of papulopustular rosacea with ivermectin

#1898
20180264020
2018-09-20

COMPOSITION FOR PREVENTION, AMELIORATION OR TREATMENT OF METABOLIC SYNDROME

#1899
20180263982
2018-09-20

Carbonic anhydrase enzymes for regulating mast cell hematopoiesis and type 2 inflammation

#1900
20180263926
2018-09-20

Restoring physiology in iron-deficient organisms using small molecules

#1901
20180263917
2018-09-20

SINGLE SOLID ORAL DOSAGE FORMS FOR TREATING HELICOBACTER PYLORI INFECTION AND DUODENAL ULCER DISEASE

#1902
20180258029
2018-09-13

Motuporamine derivatives as antimicrobial agents and antibiotic enhancers against resistant gram-negative bacteria

#1903
20180256725
2018-09-13

AQUEOUS DRUG DELIVERY SYSTEM

#1904
20180256666
2018-09-13

Method of making solanaceae fruit extracts

#1905
20180256663
2018-09-13

Compositions and methods useful in treatment of lower urinary tract symptoms, benign prostatic hyperplasia, erectile dysfunction and other diseases or symptoms

#1906
20180256659
2018-09-13

Method of using a composition in the treatment of obesity

#1907
20180256621
2018-09-13

Composition of trigofoenoside and flavonoids and methods thereof

#1908
20180256620
2018-09-13

Edible composition

#1909
20180256618
2018-09-13

Antiviral supplement formulations

#1910
20180250319
2018-09-06

ANTIFUNGAL AND ANTIPARASITIC POLYENE MACROLIDES

#1911
20180243332
2018-08-30

Method of treating or ameliorating skin conditions with a magnetic dipole stabilized solution

#1912
20180243269
2018-08-30

Forazolines, compositions thereof and uses thereof

#1913
20180243195
2018-08-30

External dermal agent for reducing yellowish dullness

#1914
20180242584
2018-08-30

Topical Avermectin Formulations and Methods For Elimination and Prophylaxis of Susceptible and Treatment Resistant Strains of Head Lice

#1915
20180235990
2018-08-23

Flavonoid compositions and related methods

#1916
20180235970
2018-08-23

Compositions and methods for increasing energy metabolism

#1917
20180235937
2018-08-23

Compounds and methods for treating an epileptic disorder

#1918
20180231553
2018-08-16

Composition for anticancer adjuvant comprising RIP3 expression promoter as active ingredient, method for screening anticancer adjuvant which promotes RIP3 expression and enhances sensitivity of anticancer agent, and method for monitoring sensitivity of anticancer agent

#1919
20180230519
2018-08-16

METHODS AND KITS FOR SELECTING TREATMENT FOR ORAL INFECTIONS

#1920
20180228941
2018-08-16

PHARMACEUTICAL COMPOSITION, SUBSTRATE COMPRISING A PHARMACEUTICAL COMPOSITION, AND USE OF A PHARMACEUTICAL COMPOSITION

#1921
20180222858
2018-08-09

DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS

#1922
20180221542
2018-08-09

Intraluminal therapy system for gastrointestinal infections

#1923
20180221499
2018-08-09

SSTR-targeted conjugates and particles and formulations thereof

#1924
20180221402
2018-08-09

Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells

#1925
20180221378
2018-08-09

Transient protection of normal cells during chemotherapy

#1926
20180221373
2018-08-09

Method of treating insomnia

#1927
20180221305
2018-08-09

ANTIMICROBIALS AND METHODS OF USE THEREOF FOR WOUND HEALING

#1928
20180214558
2018-08-02

COSMETIC AND PHARMACEUTICAL FOAM

#1929
20180214471
2018-08-02

Composition for preventing and treating osteoporosis, comprising dihydrophaseic acid 3′-O-β-D-glucopyranoside isolated from lycium root bark extracts

#1930
20180207293
2018-07-26

NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE

#1931
20180207225
2018-07-26

METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF FRIEDREICH'S ATAXIA

#1932
20180207217
2018-07-26

Method for relieving memory dysfunction using Puerariae radix extract

#1933
20180207188
2018-07-26

TREATMENT OF PAPULOPUSTULAR ROSACEA WITH IVERMECTIN

#1934
20180207187
2018-07-26

Composition for optic nerve protection

#1935
20180207099
2018-07-26

NON-MECHANICAL PROCESS FOR THE MICRONIZATION OF DIGOXIN

#1936
20180200278
2018-07-19

Pharmaceutical composition, methods for treating and uses thereof

#1937
20180200277
2018-07-19

Therapeutic agent for myotonic dystrophy

#1938
20180200224
2018-07-19

Antiviral Activity from Medicinal Mushrooms and Their Active Constituents

#1939
20180200223
2018-07-19

Application of naringenin and naringin in tumor radiotherapy

#1940
20180200195
2018-07-19

STABILIZED HIGH DRUG LOAD NANOCARRIERS, METHODS FOR THEIR PREPARATION AND USE THEREOF

#1941
20180199573
2018-07-19

CHEWABLE COMPOSITION COMPRISING A PHARMACEUTICALLY ACTIVE INGREDIENT

#1942
20180193622
2018-07-12

System, retainer and method of preventing and treating nosocomial infections including methicillin-resistant infections

#1943
20180193427
2018-07-12

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#1944
20180193400
2018-07-12

Compositions for reducing appetite and craving, increasing satiety, enhancing mood, and reducing stress

#1945
20180193370
2018-07-12

Dosage regimen for a tiacumicin compound

#1946
20180193263
2018-07-12

Extracellular vesicles derived from osteoblastic lineage cells for therapeutic and diagnostic use

#1947
20180185511
2018-07-05

Targeted structure-specific particulate delivery systems

#1948
20180185491
2018-07-05

Cochleates made with soy phosphatidylserine

#1949
20180185451
2018-07-05

Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug

#1950
20180185402
2018-07-05

Use of pimobendan for the reduction of heart size in mammals suffering from heart failure

#1951
20180185336
2018-07-05

PARASITICIDAL ORAL VETERINARY COMPOSITIONS COMPRISING SYSTEMICALLY-ACTING ACTIVE AGENTS, METHODS AND USES THEREOF

#1952
20180185334
2018-07-05

COMPOSITIONS AND METHODS FOR INHIBITING LEISHMANIA

#1953
20180185291
2018-07-05

Pharmaceutical compositions

#1954
20180185288
2018-07-05

Methods and devices for treating a retinal detachment

#1955
20180185285
2018-07-05

Milk-derived microvesicle compositions and related methods

#1956
20180177813
2018-06-28

TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA WITH IVERMECTIN

#1957
20180177794
2018-06-28

METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING AN SGLT-2 INHIBITOR AND A NEUROLEPTIC AGENT

#1958
20180177730
2018-06-28

Microspheres containing anthelmintic macrocyclic lactones

#1959
20180171411
2018-06-21

GFRalpha1 AS A BIOMARKER FOR CISPLATIN-INDUCED CHEMORESISTANCE AND METASTASIS

#1960
20180169145
2018-06-21

COMPOSITIONS AND METHODS FOR USING LAMELLAR BODIES FOR THERAPEUTIC PURPOSES

#1961
20180169126
2018-06-21

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#1962
20180169043
2018-06-21

COMPOSITIONS AND METHODS FOR THE REDUCTION OR PREVENTION OF HEPATIC STEATOSIS

#1963
20180161384
2018-06-14

Vaporized medicants and methods of use

#1964
20180155286
2018-06-07

Antibiotic sensitivity-restoring and photosensitive agents

#1965
20180153995
2018-06-07

USE OF ANTIMICROBIAL POLYMERS FOR RE-SENSITIZATION OF MICROORGANISMS UPON EMERGENCE OF RESISTANCE TO ANTI-MICROBIAL AGENTS

#1966
20180153918
2018-06-07

LIPID-BASED COMPOSITIONS OF ANTIINFECTIVES FOR TREATING PULMONARY INFECTIONS AND METHODS OF USE THEREOF

#1967
20180147226
2018-05-31

METHODS AND ASSAYS FOR COMBINATION TREATMENT OF CANCER

#1968
20180141990
2018-05-24

Acylated glucagon analogues

#1969
20180140702
2018-05-24

Shape memory particles for biomedical uses

#1970
20180140653
2018-05-24

Compositions, kits and methods for treating type II diabetes mellitus

#1971
20180140633
2018-05-24

Methods of treating a treatment-resistant gastrointestinal spasm with an oxidized tannin

#1972
20180133278
2018-05-17

PLANT-BASED BIOLOGICALLY ACTIVE SUBSTANCE HAVING A POLYPHARMACOLOGICAL EFFECT

#1973
20180133243
2018-05-17

METHOD AND COMPOSITION FOR CRUDE FORMULATIONS OF FORTIFIED SUGAR FOR GLYCEMIC CONTROL

#1974
20180133239
2018-05-17

THERAPEUTIC COMPOSITION

#1975
20180133238
2018-05-17

ORAL ADMINISTRATION OF ANTHOCYANINS, ANTHOCYANIDINS, AND THEIR METABOLITES FOR THE TREATMENT OF INFLAMMATION IN AN INFLAMMED JOINT

#1976
20180127755
2018-05-10

Targeting microRNAs for the treatment of liver cancer

#1977
20180125978
2018-05-10

Solid Carriers for Improved Delivery of Active Ingredients in Pharmaceutical Compositions

#1978
20180125974
2018-05-10

Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria

#1979
20180125873
2018-05-10

Analogues of etoposide for the treatment of tumours

#1980
20180125872
2018-05-10

Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimine

#1981
20180125831
2018-05-10

Combination therapies for treating cancer

#1982
20180125753
2018-05-10

Pharmaceutical compounding methods and systems

#1983
20180119206
2018-05-03

Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens

#1984
20180117065
2018-05-03

FXR agonist compositions for combination therapy

#1985
20180117003
2018-05-03

Methods and compositions for preventing or treating fatty liver, protecting liver function or ameliorating liver diseases caused by fatty liver or other associated disorders

#1986
20180110939
2018-04-26

METHOD, SYSTEM AND APPARATUS FOR CONTROLLED DELIVERY OF OPIOID AND OTHER MEDICATIONS

#1987
20180110825
2018-04-26

Enteric combination therapy

#1988
20180104270
2018-04-19

COMPOSITIONS AND METHODS FOR TREATING DISEASE STATES ASSOCIATED WITH ACTIVATED T CELLS AND/OR B CELLS

#1989
20180104269
2018-04-19

COMPOSITION FOR SUPPRESSING MUSCULAR FATTY CHANGE

#1990
20180104268
2018-04-19

METHODS AND PHARMACEUTICAL COMPOSITIONS COMPRISING A SGLT2 INHIBITOR FOR TREATING OR IMPROVING ERECTILE DYSFUNCTION

#1991
20180104249
2018-04-19

PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF

#1992
20180104248
2018-04-19

Theacrine-based supplement and method of use thereof in a synergistic combination with caffeine

#1993
20180104194
2018-04-19

Antimicrobials and methods of use thereof for wound healing

#1994
20180104185
2018-04-19

LIQUID COMPOSITIONS CAPABLE OF FOAMING AND INCLUDING ACTIVE AGENTS, AND METHODS FOR MAKING OR DEVELOPING SAME

#1995
20180094038
2018-04-05

Acylated glucagon analogue

#1996
20180092956
2018-04-05

Composition for amelioration of peri- and post-menopausal symptoms and a process for producing the same

#1997
20180092936
2018-04-05

Process for producing a particulate composition comprising an hydrous crystalline 2-o-alpha-d-glucosyl-ascorbic acid

#1998
20180092914
2018-04-05

Pharmaceutical compositions containing clofazimine for inhibiting activity

#1999
20180092871
2018-04-05

Antimicrobials and methods of use thereof

#2000
20180092862
2018-04-05

Antimicrobials and methods of use thereof for wound healing

#2001
20180085470
2018-03-29

ANTI-WALL TEICHOIC ANTIBODIES AND CONJUGATES

#2002
20180085432
2018-03-29

STING (Stimulator of Interferon Genes), A Regulator of Innate Immune Responses

#2003
20180071370
2018-03-15

Method to improve safety and efficacy of anti-cancer therapy

#2004
20180071329
2018-03-15

Targeting fungi in combination with cancer therapy

#2005
20180071244
2018-03-15

USE OF DIANHYDROGALACTITOL OR DERIVATIVES OR ANALOGS THEREOF FOR TREATMENT OF PEDIATRIC CENTRAL NERVOUS SYSTEM MALIGNANCIES

#2006
20180071235
2018-03-15

Antimicrobials and methods of use thereof

#2007
20180071214
2018-03-15

Pharmaceutical Oral Dose Formulation and Composition of Matter

#2008
20180064777
2018-03-08

Skin Solution with Solubilized Bakuchiol

#2009
20180064774
2018-03-08

Compositions for use in the treatment of tumors resistant to chemotherapy

#2010
20180064649
2018-03-08

PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION

#2011
20180057813
2018-03-01

Compositions and methods for nucleic acid transfer

#2012
20180057524
2018-03-01

Compounds from invasive Salvinias and methods of using the same

#2013
20180055866
2018-03-01

Control release of fat soluble antioxidants from an oral formulation and method

#2014
20180055802
2018-03-01

NUTRITIONAL COMPOSITIONS AND ASSOCIATED METHODS

#2015
20180055798
2018-03-01

Antimicrobials and methods of use thereof

#2016
20180055795
2018-03-01

Siderophore-polymer conjugates for increasing bacterial sensitivity to antibiotics

#2017
20180055778
2018-03-01

Extended-release topiramate capsules

#2018
20180050994
2018-02-22

RUFINAMIDE AND DERIVATIVES AND THEIR USE IN MODULATING THE GATING PROCESS OF HUMAN VOLTAGE-GATED SODIUM CHANNELS

#2019
20180050074
2018-02-22

Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye

#2020
20180050073
2018-02-22

Traditional Chinese medicine composition for treating prostate cancer, preparation method and application thereof

#2021
20180049981
2018-02-22

Preparation of an oil-in-water emulsion for polymer stabilized pharmaceutical formulations

#2022
20180042976
2018-02-15

Method of treating neurological conditions with extract of species or species

#2023
20180042952
2018-02-15

Etoposide and prodrugs thereof for use in targeting cancer stem cells

#2024
20180042849
2018-02-15

Cochleates and methods of using the same to enhance tissue penetration of pharmacologically active agent

#2025
20180036328
2018-02-08

Method of improving lacrimal secretion for dry eye treatment using maqui berry extract

#2026
20180036327
2018-02-08

Composition and method for treating acute respiratory tract infections

#2027
20180036292
2018-02-08

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS

#2028
20180036279
2018-02-08

Multivitamin capable of beneficial gene regulation through microRNA (miRNA)

#2029
20180029997
2018-02-01

Quinazolinone antibiotics

#2030
20180028584
2018-02-01

Composition for preventing, alleviating or treating burnout syndrome

#2031
20180028578
2018-02-01

Microbiota restoration therapy (MRT), compositions and methods of manufacture

#2032
20180028551
2018-02-01

Treatment of diseases using combination of ultraviolet blood irradiation and antibiotics

#2033
20180028550
2018-02-01

Use of albiflorin or pharmaceutically acceptable salt for prevention and/or treatment of irritable bowel syndrome

#2034
20180028549
2018-02-01

Stable antibacterial composition

#2035
20180028548
2018-02-01

Pharmaceutical compositions

#2036
20180028547
2018-02-01

Compound from the avermectin family for treating and/or preventing folliculitis

#2037
20180028546
2018-02-01

Compounds and compositions for improving power output and oxygen efficiency

#2038
20180028499
2018-02-01

5HT agonists for treating disorders

#2039
20180023030
2018-01-25

Process for the fractionation of seeds from oleaginous plants

#2040
20180021485
2018-01-25

METHOD FOR MANUFACTURING DRUG-CONTAINING BIODEGRADABLE FIBER MATERIAL BY ELECTROSPINNING

#2041
20180021397
2018-01-25

Compositions for enhancing brain activity

#2042
20180021395
2018-01-25

EUCOMMIA LEAF EXTRACT, AND PREPARATION METHOD AND USE THEREOF

#2043
20180021257
2018-01-25

WATER-SOLUBLE PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE THERAPEUTICALLY ACTIVE SUBSTANCE AND AT LEAST ONE SUBSTANCE CAPABLE OF FORMING MICELLES

#2044
20180016584
2018-01-18

Methods and compositions for unsilencing imprinted genes

#2045
20180015166
2018-01-18

POLYAPHRONS AND PALPEBRAL ADMINISTRATION THEREOF

#2046
20180015115
2018-01-18

RESTORING PHYSIOLOGY WITH SMALL MOLECULE MIMICS OF MISSING PROTEINS

#2047
20180015070
2018-01-18

METHODS AND COMPOSITIONS FOR UPREGULATING ENDOGENOUS ANTIOXIDANT SYSTEMS

#2048
20180015069
2018-01-18

ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS OR PRECURSORS THEREOF

#2049
20180009822
2018-01-11

Furoquinolinediones as inhibitors of TDP2

#2050
20180008573
2018-01-11

METHODS AND COMPOSITIONS FOR REDUCING DAMAGE ASSOCIATED WITH OXIDATIVE PHOSPHORYLATION

#2051
20180007945
2018-01-11

Methods and compositions for supporting endogenous systems related to life span

#2052
20180007904
2018-01-11

Pesticidal active mixtures comprising isoxazoline compounds I

#2053
20180002399
2018-01-04

FGFR1 EXTRACELLULAR DOMAIN COMBINATION THERAPIES

#2054
20180000897
2018-01-04

Method of treating pain using agents that promote neuronal differentiation

#2055
20180000862
2018-01-04

Methods of treating a treatment-resistant gastrointestinal spasm

#2056
20180000854
2018-01-04

STABLE FORMULATIONS FOR THE ORAL ADMINISTRATION OF AMPHOTERICIN B AND RELATED METHODS

#2057
20180000852
2018-01-04

Method of treating neurological conditions with oleandrin

#2058
20170373636
2017-12-28

SNS-595 AND METHODS OF USING THE SAME

#2059
20170369651
2017-12-28

CYCLODEXTRIN-BASED POLYMERS FOR DELIVERING THE THERAPEUTIC AGENTS COVALENTLY BOUND THERETO

#2060
20170368194
2017-12-28

CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY

#2061
20170368090
2017-12-28

Methods and materials for reducing the risk of infections

#2062
20170368089
2017-12-28

COMPOSITION FOR PREVENTING OR TREATING COLITIS

#2063
20170368088
2017-12-28

Treatment of filarial diseases

#2064
20170368087
2017-12-28

PHARMACEUTICAL COMPOSITION COMPRISING TOPIRAMATE

#2065
20170368086
2017-12-28

PAEONIFLORIN PREPARATIONS AND USES THEREOF FOR FAT REDUCTION

#2066
20170367995
2017-12-28

TREATMENT OF EARLY STAGE PARKINSON'S DISEASE WITH A HYDROXYTYROSOL-CONTAINING POLYPHENOL FORMULATION

#2067
20170363635
2017-12-21

Methods of treating and prognosing nonhematopoietic malignant tumors

#2068
20170360908
2017-12-21

Vaccine pharmaceutical composition for cell-mediated immunity containing bisphosphonates

#2069
20170360819
2017-12-21

PROCESS FOR PRODUCING A PARTICULATE COMPOSITION COMPRISING AN HYDROUS CRYSTALLINE 2-O-ALPHA-D-GLUCOSYL-L-ASCORBIC ACID

#2070
20170360816
2017-12-21

Methods for treating pulmonary non-tuberculous mycobacterial infections

#2071
20170355964
2017-12-14

Delta133p53beta and delta133p53gamma isoforms are biomarkers of cancer stem cells

#2072
20170355724
2017-12-14

ANTHELMINTHIC MACROLIDE SYNTHESIS

#2073
20170355684
2017-12-14

Crystalline isoxazole hydroxamic acid compounds

#2074
20170348384
2017-12-07

Treatment of rhinosinusitis with P-glycoprotein inhibitors

#2075
20170348381
2017-12-07

FORMULATION

#2076
20170348340
2017-12-07

NEW C-GLYCOSYLPOLYPHENOL ANTIDIABETIC AGENTS, EFFECT ON GLUCOSE TOLERANCE AND INTERACTION WITH BETA-AMYLOID. THERAPEUTIC APPLICATIONS OF THE SYNTHESIZED AGENT(S) AND OF GENISTA TENERA ETHYL ACETATE EXTRACTS CONTAINING SOME OF THOSE AGENTS

#2077
20170348339
2017-12-07

COMPOSITIONS AND METHOD OF USE OF A-TYPE PROCYANIDINS

#2078
20170340691
2017-11-30

An Antimicrobial Composition

#2079
20170340595
2017-11-30

Compositions and methods for treating autism spectrum disorders

#2080
20170333475
2017-11-23

Food supplement for restoring male sex drive (libido)

#2081
20170333467
2017-11-23

COMPOSITIONS AND METHODS FOR TREATING AN INFECTION

#2082
20170333465
2017-11-23

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#2083
20170333464
2017-11-23

Compositions and methods for treating an infection

#2084
20170333413
2017-11-23

Enhancement of tumor response to chemotherapy by activation of the ASMase/ceramide pathway through timed administration of a short-acting anti-angiogenic agent

#2085
20170326167
2017-11-16

Compositions and Methods for Treating an Infection

#2086
20170319705
2017-11-09

Amphotericin B derivatives

#2087
20170319612
2017-11-09

INHIBITION OF NONSENSE MEDIATED MRNA DECAY BY DRUGS THAT PREVENT HYPUSINATION OF EUKARYOTIC INITIATION FACTOR 5A

#2088
20170315031
2017-11-02

Tissue and cell stain formula with a novel molecule obtained from Papaver Rhoeas

#2089
20170312330
2017-11-02

Methods of increasing fertility of a male subject with costus speciosus extract

#2090
20170312278
2017-11-02

Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines

#2091
20170312256
2017-11-02

TRANSDERMAL PARASITICIDAL FORMULATIONS

#2092
20170306015
2017-10-26

Binding molecules, especially antibodies, binding to L1CAM (CD171)

#2093
20170305953
2017-10-26

14-membered ketolides and methods of their preparation and use

#2094
20170304450
2017-10-26

PARENTERAL COMPOSITIONS AND USES THEREOF

#2095
20170304341
2017-10-26

METHODS FOR TREATING AND PREVENTING MUCOSITIS

#2096
20170304340
2017-10-26

Compound of the avermectin family or of the milbemycin family for the treatment and/or prevention of atopic dermatitis

#2097
20170296668
2017-10-19

METHODS OF INCREASING SOLUBILITY OF POORLY SOLUBLE COMPOUNDS AND METHODS OF MAKING AND USING FORMULATIONS OF SUCH COMPOUND

#2098
20170296568
2017-10-19

SIRTUIN GENE POTENTIATOR, AND PHARMACEUTICAL PRODUCT, COSMETIC PRODUCT, AND FOOD PRODUCT USING SAME

#2099
20170296566
2017-10-19

METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING MUCOSITIS

#2100
20170296502
2017-10-19

Methods and compositions for increasing the potency of antifungal agents